Department of General Practice, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht (UMCU), Utrecht University, Utrecht, The Netherlands.
Erasmus School of Health Policy and Management, Erasmus University, Rotterdam, The Netherlands.
Br J Clin Pharmacol. 2019 Oct;85(10):2321-2331. doi: 10.1111/bcp.14041. Epub 2019 Jul 25.
To evaluate the effect of non-dispensing pharmacists (NDPs) integrated in general practice on medication-related hospitalisations, drug burden index and costs in patients at high risk of medication problems (being 65 years or older and using 5 or more chronic medications).
This was a multicentre, nonrandomised, controlled intervention study with pre-post comparison (2013 vs June 2014 to May 2015) in 25 general practices in the Netherlands, comparing NDP-led care (intervention) with 2 current pharmaceutical care models (usual care and usual care plus). In the intervention group, 10 specially trained NDPs were employed in general practices to take integral responsibility for the pharmaceutical care. They provided a broad range of medication therapy management services both on patient level (e.g. clinical medication review) and practice level (e.g. quality improvement projects). In the control groups, pharmaceutical care was provided as usual by general practitioners and community pharmacists, or as usual plus, when pharmacists were additionally trained in performing medication reviews.
Overall, 822 medication-related hospitalisations were identified among 11 281 high-risk patients during the intervention period. After adjustment for clustering and potential confounders, the rate ratio of medication-related hospitalisations in the intervention group compared to usual care was 0.68 (95% confidence interval: 0.57-0.82) and 1.05 (95% confidence interval: 0.73-1.52) compared to usual care plus. No differences in drug burden index or costs were found.
In general practices with an integrated NDP, the rate of medication-related hospitalisations is lower compared to usual care. No differences with usual care plus were found.
评估综合实践中的非处方药剂师(NDPs)对高药物风险患者(65 岁或以上且使用 5 种或更多慢性药物)的药物相关住院治疗、药物负担指数和成本的影响。
这是一项多中心、非随机、对照干预研究,在荷兰的 25 家综合实践中进行,比较了 NDP 主导的护理(干预)与 2 种当前的药物护理模式(常规护理和常规护理加)。在干预组中,10 名经过专门培训的 NDP 受雇于综合实践,负责药物护理的整体责任。他们提供广泛的药物治疗管理服务,包括患者层面(如临床药物审查)和实践层面(如质量改进项目)。在对照组中,药物护理由全科医生和社区药剂师按常规提供,或在药剂师接受药物审查培训时按常规加提供。
在干预期间,共确定了 11281 名高风险患者中的 822 例与药物相关的住院治疗。调整聚类和潜在混杂因素后,与常规护理相比,干预组与药物相关的住院治疗的比率比为 0.68(95%置信区间:0.57-0.82),与常规护理加相比为 1.05(95%置信区间:0.73-1.52)。未发现药物负担指数或成本存在差异。
在综合实践中,整合了 NDP 的情况下,药物相关住院治疗的发生率低于常规护理。与常规护理加相比,没有发现差异。